Trademark Overview
On Tuesday, June 17, 2025, a trademark application was filed for BIOSOMICS with the United States Patent and Trademark Office. The USPTO has given the BIOSOMICS trademark a serial number of 79430818. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, June 17, 2026. This trademark is owned by LINKCARE HEALTH SERVICES, S.L.. The BIOSOMICS trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical Instrument Products categories with the following description:
Chemical products being preparations for analysis in laboratories, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; diagnostic preparations and reagents, other than for medical or veterinary use; chemical products, namely, diagnostic preparations for diagnostic scientific purposes; chemical reagents for clinical diagnosis, except for medical or veterinary use; diagnostic kits comprising immunoassay reagents, antibodies, calibrators and assay controls for scientific use, and sample collection tubes, microplates and assay cartridges for analyzing selected bacteria; chemical products for use in immunoassay testing being immunoassay reagents, antibodies and assay controls, other than for medical or veterinary use; immunoassay reagents, other than for medical and veterinary use
Medical apparatus and instruments, namely, in vitro diagnostic devices for the screening, detection, evolution and treatment response of diseases based on the analysis of biomarkers in neuron-derived extracellular vesicles; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing in vitro diagnostic, devices for the screening, detection, evolution and treatment response monitoring of cancer and neurodegenerative diseases based on the analysis of biomarkers in cancer-derived and neuron-derived extracellular vesicles; detector apparatus for medical use in diagnosis namely, medical diagnostic apparatus for testing in vitro diagnostic devices used for the screening, detection, evolution and treatment response monitoring of cancer and neurodegenerative diseases based in the analysis of biomarkers in cancer-derived extracellular vesicles; apparatus for diagnostic testing for medical purposes, namely for the detection of cancer and neurodegenerative diseases; med...
Preparations for medical use, namely, pharmaceutical preparations for treating skin disorders; biological preparations for use in cell cultures for medical use; chemical preparations for medical use, namely, diagnostic reagents for medical use for the detection, diagnosis, prognosis and monitoring of neurodegenerative diseases, oncological diseases and other medical conditions, diagnostic biomarker reagents for medical purposes, immunoassay reagents for medical diagnostics, and reagents for the analysis of extracellular vesicles and biological samples for medical diagnostic purposes; chemico-pharmaceutical preparations for the treatment and detection of cancer and neurodegenerative disorders; diagnostic preparations for medical use; chemical reagents for medical or veterinary use; diagnostic reagents for medical use; reagents for clinical diagnosis, namely, clinical medical reagents; reagents for clinical analyses for medical use; reagents with biomarkers for medical diagnostics; immun...
